302 related articles for article (PubMed ID: 12764100)
1. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V
J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100
[TBL] [Abstract][Full Text] [Related]
2. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
Di Marzo V; Griffin G; De Petrocellis L; Brandi I; Bisogno T; Williams W; Grier MC; Kulasegram S; Mahadevan A; Razdan RK; Martin BR
J Pharmacol Exp Ther; 2002 Mar; 300(3):984-91. PubMed ID: 11861807
[TBL] [Abstract][Full Text] [Related]
3. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
[TBL] [Abstract][Full Text] [Related]
4. VR1-mediated depressor effects during high-salt intake: role of anandamide.
Wang Y; Kaminski NE; Wang DH
Hypertension; 2005 Oct; 46(4):986-91. PubMed ID: 16144988
[TBL] [Abstract][Full Text] [Related]
5. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
6. Exogenous anandamide protects rat brain against acute neuronal injury in vivo.
van der Stelt M; Veldhuis WB; van Haaften GW; Fezza F; Bisogno T; Bar PR; Veldink GA; Vliegenthart JF; Di Marzo V; Nicolay K
J Neurosci; 2001 Nov; 21(22):8765-71. PubMed ID: 11698588
[TBL] [Abstract][Full Text] [Related]
7. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
De Petrocellis L; Bisogno T; Davis JB; Pertwee RG; Di Marzo V
FEBS Lett; 2000 Oct; 483(1):52-6. PubMed ID: 11033355
[TBL] [Abstract][Full Text] [Related]
8. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.
Roberts LA; Christie MJ; Connor M
Br J Pharmacol; 2002 Oct; 137(4):421-8. PubMed ID: 12359623
[TBL] [Abstract][Full Text] [Related]
9. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
Malinowska B; Kwolek G; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
[TBL] [Abstract][Full Text] [Related]
11. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.
Edgemond WS; Hillard CJ; Falck JR; Kearn CS; Campbell WB
Mol Pharmacol; 1998 Jul; 54(1):180-8. PubMed ID: 9658204
[TBL] [Abstract][Full Text] [Related]
12. New perspectives on enigmatic vanilloid receptors.
Szallasi A; Di Marzo V
Trends Neurosci; 2000 Oct; 23(10):491-7. PubMed ID: 11006466
[TBL] [Abstract][Full Text] [Related]
13. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response.
Hermann H; De Petrocellis L; Bisogno T; Schiano Moriello A; Lutz B; Di Marzo V
Cell Mol Life Sci; 2003 Mar; 60(3):607-16. PubMed ID: 12737320
[TBL] [Abstract][Full Text] [Related]
14. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
Brooks JW; Pryce G; Bisogno T; Jaggar SI; Hankey DJ; Brown P; Bridges D; Ledent C; Bifulco M; Rice AS; Di Marzo V; Baker D
Eur J Pharmacol; 2002 Mar; 439(1-3):83-92. PubMed ID: 11937096
[TBL] [Abstract][Full Text] [Related]
15. Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity.
Kim SR; Chung YC; Chung ES; Park KW; Won SY; Bok E; Park ES; Jin BK
Mol Neurobiol; 2007 Jun; 35(3):245-54. PubMed ID: 17917113
[TBL] [Abstract][Full Text] [Related]
16. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
[TBL] [Abstract][Full Text] [Related]
18. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
Jerman JC; Gray J; Brough SJ; Ooi L; Owen D; Davis JB; Smart D
Br J Anaesth; 2002 Dec; 89(6):882-7. PubMed ID: 12453933
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors.
Marinelli S; Di Marzo V; Berretta N; Matias I; Maccarrone M; Bernardi G; Mercuri NB
J Neurosci; 2003 Apr; 23(8):3136-44. PubMed ID: 12716921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
